3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Mouth Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Sentinel Lymph Node Biopsy (SLNB)
1
Sarcoidosis, Pulmonary
1
Sarcoidosis
1
Rhabdomyosarcoma
1
Recurrence
1
Recurent Vulvar Carcinoma
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Melanoma
1
Lymphoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
HIV Infections
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Eyelid Sebaceous Gland Carcinoma
1
Cervical Adenocarcinoma
1
Carcinoma, Ductal
1
Anus Neoplasms
1
Interventions
pembrolizumab
26
Cisplatin
24
Carboplatin
19
Magnetic Resonance Spectroscopy
16
Paclitaxel
15
Specimen Handling
14
Pemetrexed
12
durvalumab
9
Radiotherapy, Intensity-Modulated
8
Platinum
8
1,2-diaminocyclohexaneplatinum II citrate
8
Nivolumab
7
Radiation
6
Docetaxel
6
Cetuximab
6
Biopsy
6
osimertinib
5
cemiplimab
5
Taxes
5
Radiotherapy
5
Ipilimumab
5
Cyclophosphamide
5
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
5
poly ICLC
4
cabozantinib
4
atezolizumab
4
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
4
Bevacizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
Sentinel Lymph Node Biopsy
×
1 year
×
Clear all
No trials found.